Statistical Considerations in the Design of Biosimilar Cancer Clinical Trials [0.03%]
生物仿制药临床试验的设计中的统计考量因素
Chul Ahn,Seung-Chun Lee
Chul Ahn
When the patent of an innovative (brand-name) small-molecule drug expires, generic copies of the innovative drug may be marketed if their therapeutic equivalence to the innovative drug has been shown. The small-molecule drugs are considered...